Lipid Sciences, Inc. (NASDAQ: LIPD) today reported financial results for the second quarter and six months ended June 30, 2006. Lipid Sciences is a development-stage biotechnology company engaged in the research and development of products and processes intended to treat major medical indications in which lipids, or fat components, play a key role. These medical indications include cardiovascular disease and viral infections, such as those caused by Human Immunodeficiency Virus (HIV).
